Howard G. Welgus, Director at Arcutis Biotherapeutics, Inc. (ARQT), sold 4,731 shares at $24.41 ($116K) on 2026-06-15, disclosed to the SEC on 2026-06-17.
Scheduled sale ($116k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.41 | 4,096 | $100K | 86.0% |
| 2 | $25.67 | 635 | $16K | 14.0% |
| Total | $24.58 avg | 4,731 | $116K | 100% |
| Filing → |
| ARQT | SELL | 2026-07-17 | $127K | — | Filing → |
| ARQT | SELL | 2026-05-05 | $164K | — | Filing → |
| ARQT | SELL | 2026-04-03 | $239K | — | Filing → |